Show simple item record

USP39 deubiquitinase is essential for KRAS oncogene-driven cancer

dc.contributor.authorMartínez Fraile, Julia 
dc.contributor.authorManchado, Eusebio
dc.contributor.authorLujambio, Amaia
dc.contributor.authorQuesada Fernández, Víctor 
dc.contributor.authorCampos Iglesias, Diana 
dc.contributor.authorWebb, Thomas R.
dc.contributor.authorLowe, Scott W.
dc.contributor.authorLópez Otín, Carlos 
dc.contributor.authorPérez Freije, José María 
dc.date.accessioned2017-12-14T11:03:46Z
dc.date.available2017-12-14T11:03:46Z
dc.date.issued2017
dc.identifier.citationJournal of Biological Chemistry, 292(10), p. 4164-4175 (2017); doi:10.1074/jbc.M116.762757
dc.identifier.issn0021-9258
dc.identifier.issn1083-351X
dc.identifier.urihttp://hdl.handle.net/10651/44757
dc.description.sponsorshipThis work was supported by grants from the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III (CIBERONC, Plan Feder), Fundacion EDP, and Principado de Asturias, Spain. The discovery and synthesis of sudemycin D1 and D6 were supported in part by National Institutes of Health Grant CA140474, the American Lebanese Syrian Associated Charities (ALSAC), and St. Jude Children's Research Hospital.
dc.format.extentp. 4164-4175
dc.language.isoeng
dc.relation.ispartofJournal Of Biological Chemistry
dc.rights© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceWOS:000404672500003
dc.titleUSP39 deubiquitinase is essential for KRAS oncogene-driven cancer
dc.typejournal article
dc.identifier.doi10.1074/jbc.M116.762757
dc.relation.publisherversionhttp://dx.doi.org/10.1074/jbc.M116.762757
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Files in this item

untranslated

This item appears in the following Collection(s)

Show simple item record

© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
This item is protected with a Creative Commons License